CD8A and nonpapillary renal cell carcinoma: On the other hand, scTCRseq results showed a significant decrease in the TCR diversity with advancing ccRCC stage, and there was a high proportion of terminally exhausted CD8+ T cells with low TCR diversity in metastatic ccRCC.